Thermo Fisher Scientific (TMO)Rep. Rob Bresnahan (PA08) disclosed a purchase $15K–$50K
Rep. Rob Bresnahan (PA08) disclosed a purchase of Thermo Fisher Scientific in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 16 days
- Disclosure lag
- Traded
- May 15, 2025
- Disclosed
- May 31, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 29, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Dec 11, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Feb 25, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Mar 3, 2025Congress · 2 peopleMembers of Congress: 2 purchases, 1 sale
- Mar 27, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Apr 7, 2025Congress · 2 peopleMembers of Congress: 2 sales
- Apr 8, 2025Congress · 2 peopleMembers of Congress: 2 sales
- Apr 11, 2025Congress · 2 peopleMembers of Congress: 2 sales
- Apr 15, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL
- Apr 21, 2025Congress · 1 personMembers of Congress: 2 sales
- Apr 28, 2025InsiderOfficer sold ~$129K of TMO shares in the open market
- Apr 29, 2025Layoff notice · 100 West Gore Street, ORLANDO, FL, 32806Layoff notice filed in FL: 59 employees
- May 5, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- May 12, 2025InsiderOfficer sold ~$164K of TMO shares in the open market
- May 13, 2025CongressDisclosed purchase of TMO — reported range $15,001 - $50,000
- May 15, 2025 · this disclosureCongressDisclosed purchase of TMO — reported range $15,001 - $50,000
What came next
- May 16, 2025CongressDisclosed sale of TMO — reported range $15,001 - $50,000
- May 22, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL
- Jun 6, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Jun 10, 2025CongressDisclosed partial sale of TMO — reported range $1,001 - $15,000
- Jun 12, 2025FDAFDA device clearance: Thermo Scientific Oxoid Aztreonam/Avibactam Disc (30/20 µg) AZA50
- Jun 20, 2025FDAFDA device clearance: The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range…
- Jun 30, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL
- Jul 2, 2025FDAFDA device approval: Oncomine Dx Express Test
- Jul 21, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
- Jul 22, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
- Jul 25, 2025InsiderOfficer sold ~$192K of TMO shares in the open market
- Jul 29, 2025Layoff notice · 5823 Newton Dr Carlsbad CA 92008Layoff notice filed in CA: 52 employees
- Jul 29, 2025Layoff notice · 5781 Van Allen Way Carlsbad CA 92008Layoff notice filed in CA: 33 employees
- Aug 6, 2025Insider · 1 personInsiders: 15 sales (~$4.5M)
- Aug 7, 2025Insider · 1 personInsiders: 5 sales (~$3.6M)
- Aug 19, 2025InsiderCEO sold ~$101K of TMO shares in the open market
- Aug 19, 2025Congress · 1 personMembers of Congress: 4 sales
- Aug 20, 2025Insider · 1 personInsiders: 2 sales (~$148K)
- Aug 22, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
- Aug 28, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Thermo Fisher Scientific
For Thermo Fisher Scientific, OQRO holds 93 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 143 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.
Other recent filings by Rep. Rob Bresnahan (PA08)
- House Clerk periodic transaction report at Berkshire Hathaway (BRK.B)Dec 19, 2025
- House Clerk periodic transaction report at Gitlab (GTLB)Jul 8, 2025
- House Clerk periodic transaction report at Amazon (AMZN)Jul 8, 2025
- House Clerk periodic transaction report at AppLovin (APP)Jul 8, 2025
- House Clerk periodic transaction report at Atlassian (TEAM)Jul 8, 2025
The full history of Rep. Rob Bresnahan (PA08) is on the profile page.
How this filing works
Other disclosures at Thermo Fisher Scientific
- USAspending.gov award recordSep 30, 2026
- USAspending.gov award recordSep 30, 2026
- USAspending.gov award recordSep 29, 2026
- USAspending.gov award recordSep 29, 2026
- USAspending.gov award recordSep 9, 2026
- SEC Form 4Sep 1, 2026
Everything OQRO holds on this company is on its TMO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
